-

Agilent to Participate at Cowen and Barclays Health Care Conferences

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Bob McMahon, senior vice president and chief financial officer, will participate in Q&A sessions at the Cowen 42nd Annual Health Care Conference and the Barclays Global Health Care Conference. Below are the details:

Cowen 42nd Annual Health Care Conference
Tuesday, March 8, 2022
11:10 a.m. EST / 8:10 a.m. PST

Barclays Global Health Care Conference
Wednesday, March 16, 2022
2:05 p.m. EDT / 11:05 a.m. PDT

Both sessions will be webcast live, and links to join them will be available in the News and Events section of Agilent’s Investor Relations website shortly before the event.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter and Facebook.

Contacts

INVESTOR CONTACT:
Parmeet Ahuja
+1 408 345 8948
parmeet_ahuja@agilent.com

MEDIA CONTACT:
Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions
$Cashtags
Hashtags

Contacts

INVESTOR CONTACT:
Parmeet Ahuja
+1 408 345 8948
parmeet_ahuja@agilent.com

MEDIA CONTACT:
Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

More News From Agilent Technologies Inc.

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving...

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time...

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis. Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the...
Back to Newsroom